Can Bioactive Lipids Augment Anti-cancer Action of Immunotherapy and Prevent Cytokine Storm?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can Bioactive Lipids Augment Anti-cancer Action of Immunotherapy and Prevent Cytokine Storm?

Published:2019-08 Issue:6 Volume:50 Page:342-349
ISSN:0188-4409
Container-title:Archives of Medical Research
language:en
Short-container-title:Archives of Medical Research

Author:

Das Undurti N.

Publisher

Elsevier BV

Subject

General Medicine

Reference94 articles.

1. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer;Zacharakis;Nat Med,2018

2. Immunotherapy: targeting the cancer mutanome of breast cancer;Radvanyi;Nat Med,2018

3. Immunotherapy: modeling cytokine release syndrome;Rooney;Nat Med,2018

4. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade;Giavridis T van der Stegen;Nat Med,2018

5. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells;Norelli;Nat Med,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a role for essential fatty acids in osteoporosis?;European Journal of Clinical Nutrition;2024-06-05

2. Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma;International Immunopharmacology;2024-03

3. Impact of serum eicosapentaenoic acid/arachidonic acid ratio on overall survival in lung cancer patients treated with pembrolizumab: a pilot study;Scientific Reports;2024-01-16

4. Research Advances on the Role of Lipids in the Life Cycle of Human Coronaviruses;Microorganisms;2023-12-28

5. Association between serum eicosapentaenoic acid/arachidonic acid ratio and overall survival in patients with non-small cell lung cancer treated with pembrolizumab;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3